1. Home
  2. UGRO vs VRAX Comparison

UGRO vs VRAX Comparison

Compare UGRO & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$2.43

Market Cap

1.8M

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.21

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGRO
VRAX
Founded
2014
2013
Country
United States
United Kingdom
Employees
130
N/A
Industry
Industrial Specialties
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.7M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
UGRO
VRAX
Price
$2.43
$0.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
181.8K
187.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,008,850.00
N/A
Revenue This Year
$98.41
$217,274.83
Revenue Next Year
$23.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.19
52 Week High
$4.50
$1.58

Technical Indicators

Market Signals
Indicator
UGRO
VRAX
Relative Strength Index (RSI) 56.25 41.74
Support Level $0.28 $0.20
Resistance Level $4.50 $0.25
Average True Range (ATR) 0.30 0.02
MACD -0.12 0.00
Stochastic Oscillator 20.94 38.85

Price Performance

Historical Comparison
UGRO
VRAX

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

Share on Social Networks: